Teens Abusing Opioids May Benefit From Medication Treatment

Teens Abusing Opioids May Benefit From Medication Treatment

Though the effectiveness of medicines to deal with adults with opioid use dysfunction has been properly established, there was little analysis about how — or even when — such remedy works in adolescents.

Now, a brand new assessment of the literature means that, along with adults, adolescents with extreme opioid use dysfunction might be handled with considered one of three medicines: methadone, buprenorphine (Subutex/Suboxone) or extended-release naltrexone (Vivitrol). The research was printed within the newest problem of the Journal of Research on Alcohol and Medicine.

“In 2017, 900 adolescents began misusing opioid ache relievers every day,” the authors write. Along with abusing prescription medicine, a few of these teenagers “provoke heroin use due to its prepared availability, decrease value, and powerful efficiency.”

“Adolescents with extreme opioid use dysfunction might profit from a drugs as half of a bigger complete remedy plan,” says lead creator Deepa R. Camenga, M.D., M.H.S., of the Yale College of Drugs. Additional, “mother and father ought to attempt to seek the advice of with an dependancy psychiatry or drugs specialist to see if there are extra therapies that will profit their baby.”

Of their analysis, Camenga and colleagues searched the scientific literature for investigations of the consequences of medicine within the remedy of opioid use dysfunction in adolescents. They recognized 14 stories, printed between 1973 and 2018. The variety of adolescents in every research ranged from only a handful to a number of hundred.

Total, the researchers report that the hazards of untreated opioid use dysfunction “far outweigh the dangers” of remedy with methadone, buprenorphine, or naltrexone. Nonetheless, few adolescents obtain such remedy: Solely about 2 to five % of adolescents with an opioid use dysfunction obtain remedy with considered one of these medicines, in contrast with 12 to 26 % of adults.

On the whole, methadone, buprenorphine and extended-release naltrexone improved the variety of adolescents who remained in remedy, decreased opioid use, and led to extra abstinence. However, the authors say, “analysis remains to be wanted to grasp the optimum remedy length and retain adolescents in remedy.”

The medicines do have their challenges. For methadone, the authors say, the usage of these medicines must be carefully monitored as a result of identified unintended effects with excessive doses, together with gradual respiration and sedation, in addition to coronary heart rhythm issues. Additional, methadone must be administered by a federally licensed opioid remedy program, which may trigger problem for adolescents who don’t have transportation to such places. Additionally, adolescents should obtain particular dispensation to obtain it, and there may be the chance that methadone itself might be abused.

Not like methadone, buprenorphine might be administered on an outpatient foundation. Nonetheless, teenagers might have the oversight of an grownup to assist make sure the medicine is taken correctly and never misused.

For naltrexone, one problem to remedy is that sufferers need to undergo cleansing earlier than beginning remedy. Additionally, naltrexone might enhance the chance of opioid overdose if a affected person begins utilizing opioids once more as soon as the medicine wears off. Nonetheless, extended-release naltrexone is given by injection as soon as a month and doesn’t require the frequent visits of methadone or the oversight of buprenorphine.

Nonetheless, there’s a very restricted variety of well being care professionals who deal with teenagers with opioid use dysfunction. “There’s a nice want to enhance adolescents’ entry to medicines for the remedy of OUD and to extend workforce capability to take care of these adolescents,” the authors conclude.

In a commentary that accompanies the assessment, a bunch of researchers led by Rachel Gonzales-Castaneda, Ph.D., M.P.H., of UCLA, writes that, as a result of relapse happens in additional than half of the adolescents handled for opioid use dysfunction with normal approaches, options such a remedy with medicine might have to be thought-about. Nonetheless, they add that researchers lack info on how medical remedy might work together with different psychological or bodily problems, or their therapies, and that rather more analysis is required that addresses the wants of the adolescent inhabitants with opioid dysfunction.

In a second commentary, Noel Vest, Ph.D., of the Stanford College College of Drugs, and Keith N. Humphreys, Ph.D., of the Veterans Affairs Palo Alto Well being Care System in California, sound a cautious tone about the usage of medicine to deal with opioid use dysfunction in adolescents.

Particularly, they write that teenagers handled with methadone “might find yourself taking the medicine for half a century or extra” and that the dangers of such prolonged remedy are unknown. Additional, they counsel that the remedy retention famous within the assessment doesn’t essentially equate to sufferers refraining from medication or alcohol.

Final, diagnosing an adolescent poses problems. “[I]t might be difficult to find out whether or not 16-year-olds are actually depending on Vicodin if they’ve been frequenting events through which they’re amongst many youngsters who devour the drug,” Vest and Humphreys write.


Camenga, D. R., Colon-Rivera, H. A., & Muvvala, S. B. (2019). Drugs for upkeep remedy of opioid use dysfunction in adolescents: A story assessment and evaluation of scientific advantages and potential dangers. Journal of Research on Alcohol and Medicine, 80, 393-402.
DOI: 10.15288/jsad.2019.80.393

Gonzales-Castaneda, R., Mooney, L. J., & Rawson, R. A. (2019). Drugs for upkeep remedy of opioid use dysfunction in adolescents: A story assessment and evaluation of scientific advantages and potential dangers, providing a public well being perspective–A commentary on Camenga et al. Journal of Research on Alcohol and Medicine, 80, 403-405.
DOI: 10.15288/jsad.2019.80.403

Vest, N., & Humphreys, Ok. N. (2019). Do we all know sufficient to prescribe opioid-agonist therapies to adolescents with problematic opioid use? A commentary on Camenga et al. (2019). Journal of Research on Alcohol and Medicine, 80, 406-407.
DOI: 10.15288/jsad.2019.80.406

For extra on this research, see Medications Can Help As Opioid Treatment for Teens.

Back to top button